List of biotech founders and drug hunters who were unlikely to succeed (and yet they did)
Robert Swanson (Genentech)
- VC who got kicked out of his job, was almost never in touch with science. Started Genentech at 28.
- Started a company in a climate where the government constantly wanted to shut them down
- Cold-mailed Boyer to be his co-founder before there was any such thing as academia-industry collaboration
- Genentech had no scientific management for years, and yet got therapy from the bench to an approved drug in a total of 4 years
- After a number of high-profile labs figured that cloning is not as dangerous as they thought and started catching up, he still outcompeted them all
Robert Duggan (Pharmacyclics)
- Scientologist who only had experience with some tech and developing a recipe for Mcdonalds' cookies
- Started buying out stock of a biotech company that was literally about to get delisted
- It didn't have anything viable in the pipeline and had no cash to develop new things
- Got first-in-class drug approved years later (Imbruvica), selling the company for $21 billion to AbbVie
Larry Bock (Illumina)
- Was legally blind by the age of 29
- Founded, co-founded & backed more than 50 companies that have achieved a cumulative market capitalization of over $100 billion
Frederick Banting (Insulin)
- Had a very slow start to his career. Failed his first degree. Got rejected from being a medic in the army twice
- After reading a 1920 scientific paper describing an experiment in which the pancreatic duct was tied off, became interested in isolating insulin
- Never managed to get a research position himself
- He was the first person to isolate medicine from an animal. No precedent before
- The youngest person to ever get a Nobel prize
James Black (first beta blocker)
- Was in huge debts by the time he graduated
- Had to take a teaching job to make ends meet
- Discovered the first beta blocker, propranolol, "the first agent to reduce blood pressure without diuretic effects"
Katalin Kariko (mRNA vaccines)
- Was demoted from the University because she couldn't get funding for her research
- The paper on nucleoside modifications she received Nobel Prize for got rejected by all major journals
Russel Earl Marker (progesterone synthesis)
- Dropped out of grad school
- Developed his own method to produce semi-synthetic progesterone from Mexican yams
- Was rejected by every single American pharma when he pitched his process
- Founded Syntex, S.A.. Left it 2 years later because he was bored
Marianna Rothblatt (United Tx)
- Underwent gender transition in the mid-1990s
- Motivated by her daughter Jenesis's diagnosis with pulmonary arterial hypertension, founded United Therapeutics in 1996
- Ended up bringing to market several treatments for PAH
- A huge company today
Arthur Kuan (CG Oncology)
- He was 26 when he took on the CEO role
- One of the best-performing IPOs in biotech in 2024